Aevis Victoria SA (SWX:AEVS)
Switzerland · Delayed Price · Currency is CHF 12.85
+0.15 (1.18%)
Apr 2, 2026, 5:30 PM CET
Aevis Victoria Revenue
In the year 2025, Aevis Victoria had annual revenue of 1.06B CHF with 19.46% growth. Aevis Victoria had revenue of 535.89M in the half year ending June 30, 2025, with 25.21% growth.
Revenue
1.06B
Revenue Growth
+13.46%
P/S Ratio
1.03
Revenue / Employee
223.01K
Employees
4,731
Market Cap
1.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.06B | 171.90M | 19.46% |
| Dec 31, 2024 | 883.16M | 50.15M | 6.02% |
| Dec 31, 2023 | 833.02M | -133.85M | -13.84% |
| Dec 31, 2022 | 966.86M | 221.95M | 29.79% |
| Dec 31, 2021 | 744.92M | 119.97M | 19.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Tecan Group AG | 882.48M |
| PolyPeptide Group AG | 362.47M |
| SKAN Group AG | 333.34M |
| Medartis Holding AG | 269.26M |
Aevis Victoria News
- 6 months ago - Aevis Victoria SA (XSWX:AEVS) Half Year 2025 Earnings Call Highlights: Strong Growth and ... - GuruFocus
- 6 months ago - Half Year 2025 Aevis Victoria SA Earnings Call Transcript - GuruFocus